NCT06051409 2026-04-30A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)Ascentage Pharma Group Inc.Phase 3 Recruiting350 enrolled
NCT07152041 2025-09-03CAMS-Ph+ B-ALLInstitute of Hematology & Blood Diseases Hospital, ChinaPhase 3 Recruiting150 enrolled